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CASE REPORT
Pyogenic liver abscess is the most common intra-
abdominal visceral abscess,1 which may arise
from contiguous infection or hematogenously.
Ascending infection from biliary tract infections
is the most common and is usually polymicro-
bial.2 However, in Taiwan, liver abscess caused
by Klebsiella pneumoniae is a frequently described
entity, especially in diabetic patients.3
Melioidosis is a systemic infection caused 
by Burkholderia pseudomallei, contracted mainly
by inoculation or inhalation.4 This disease is
endemic in Southeast Asia and northern Australia,
especially during the rainy season.5 Taiwan is 
tgeographically located in similar latitudes, bu
 was not regarded as an endemic area until
indigenous cases were reported in 1992.6 Melioi-
dosis is known for its propensity to cause
abscesses,7 and may cause liver abscesses, with
fconcomitant splenic abscesses in up to 56% o
patients. It often develops in diabetic patients
yin whom it is associated with a higher mortalit
and relapse rate.
We report three cases of liver abscess caused
by B. pseudomallei as a reminder that melioidosis
should be included in the differential diagnosis
of patients with liver abscess in Taiwan.
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Pyogenic liver abscess in Taiwan is a well-known disease entity, commonly associated with a single pathogen,
Klebsiella pneumoniae. Melioidosis is an endemic disease in Taiwan that can manifest as multiple abscesses
in sites including the liver. We report three cases of liver abscesses caused by Burkholderia pseudomallei. The
first patient was a 54-year-old diabetic woman, who presented with liver abscess and a left subphrenic 
abscess resulting from a ruptured splenic abscess, co-infected with K. pneumoniae and B. pseudomallei. The
second patient, a 58-year-old diabetic man, developed bacteremic pneumonia over the left lower lung due
to B. pseudomallei cwith acute respiratory distress syndrome, and relapsed 5 months later with bacteremi  
cabscesses of the liver, spleen, prostate and osteomyelitis, due to lack of compliance with prescribed antibioti
therapy. The third patient was a 61-year-old diabetic man with a history of travel to Thailand, who presented
with jaundice and fever of unknown origin. Liver and splenic abscesses due to B. pseudomallei were diag-
nosed. A high clinical alertness to patients’ travel history, underlying diseases, and the presence of concomi-
tant splenic abscess is essential to early detection of the great mimicker, melioidosis. The treatment of choice
is intravenous ceftazidime for at least 14 days or more. An adequate duration of maintenance oral therapy,
with amoxicillin-clavulanate or trimethoprim-sulfamethoxazole for 12–20 weeks, is necessary to prevent 
relapse. Liver abscess in Taiwan is most commonly due to K. pneumoniae, but clinicians should keep in mind
that this may be a presenting feature of melioidosis. [J Formos Med Assoc 2006;105(8):689–693]
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Case Reports
Case 1
A 54-year-old diabetic woman presented with
fever and chills for 10 days. She reported no
travel history to China. Physical examination
showed an acutely ill appearance and knocking
tenderness was elicited over the left upper quad-
rant of the abdomen.
Sonogram and computed tomography (CT)
scan of the abdomen showed multifocal hypo-
densities in the left lobe (S4) of the liver and
splenic abscess with rupture to the left sub-
phrenic space. Culture of the aspirated pus iso-
lated K. pneumoniae and B. pseudomallei. Blood
culture showed no growth. Ceftazidime 2 g was
given every 8 hours for 30 days, followed by oral
minocycline with amoxicillin-clavulanate for 28
days. Antibiotics treatment was then switched to
trimethoprim/sulfamethoxazole (TMP/SMX) for
a total of 8 months at the outpatient clinic. She
was well at follow-up 2 months later, and there
was no relapse over the next 2 years.
Case 2
A 58-year-old diabetic man presented with fever,
vomiting and diarrhea for 3 days. He also had
hypertension and chronic hepatitis B. He had
worked as a fisherman in the sea around Indonesia
and the Philippines.
Five months before this admission, bac-
teremic B. pseudomallei pneumonia over the left
lower lung complicated with acute respiratory
distress syndrome (ARDS) was diagnosed and he
was treated with ceftazidime 2 g every 8 hours for
3 weeks and oral TMP/SMX (TMP 80 mg; SMX
400 mg) two tablets every 6 hours for 6 weeks.
He was lost to follow-up thereafter.
During presentation, he appeared acutely ill
with impaired liver and renal function. Physical
examination elicited local tenderness over the
right upper quadrant of the abdomen. CT of the
abdomen disclosed multiple abscesses over both
lobes of the liver, spleen, and prostate (Figure).
Two sets of blood culture grew B. pseudomallei.
Osteomyelitis scan showed increased uptake over
the right shoulder, proximal humerus, proximal
cfemur and left femoral head. Relapse of septicemi
B. pseudomallei with multiple organ (liver, spleen,
prostate, bone) involvement due to incomplete
maintenance treatment was diagnosed. Ceftazi-
dime 2g every 8 hours was given for a total of 18
days and then changed to amoxicillin-clavulanate
two tablets every 8 hours for 4 months. He was well
at follow-up at the outpatient clinic 1 year later.
Case 3
A 61-year-old diabetic man presented with epigas-
tralgia, fever and progressive jaundice for 1 week.
gAsymptomatic gallstone had been found durin  
a routine health check up 1 year previously. He
had traveled to Thailand 2 years previously and
suffered from fever of unknown cause upon return
to Taiwan.
He visited a regional hospital initially, where
gallstone with acute cholecystitis was diagnosed.
Laparoscopic cholecystectomy was performed,
but jaundice and fever persisted. He was then
admitted to our hospital.
CT of the abdomen disclosed at least three low-
density areas over the right lobe of the liver with
yperipheral enhancement, and one low-densit
area within the spleen. The pus from the postop-
erative drainage tube grew B. pseudomallei r. Fou
sets of blood culture were negative. Cefazolin, gen-
rtamicin and metronidazole were given initially fo
the treatment of intra-abdominal infec ttion, bu
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multiple abscesses over both lobes of the liver, spleen and
prostate.
Melioidosis presenting as liver abscess
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his fever persisted. Ceftazidime 2 g every 8 hours
was given for a total of 14 days, and then it was
switched to oral amoxicillin-clavulanate (375 mg;
amoxicillin trihydrate 250 mg + clavulanic acid
125 mg) two tablets every 8 hours for a total of 6
months. He was well without relapse at follow-
up 1 year later.
Discussion
Pyogenic liver abscess is an uncommon compli-
cation of intra-abdominal infection, usually aris-
ing from a biliary source in around 30–35% of
cases.2 The etiology is often polymicrobial, with
Escherichia coli, the most often cultured bacteria,
accounting for about 35–40% of the cases.8
In Taiwan, liver abscess is most often caused by
a single pathogen, K. pneumoniae. This pathogen
accounted for 30% of liver abscesses in the 1980s
to 80% in the 1990s.9 The estimated incidence is
over 200 cases annually in Taiwan. Melioidosis is
a systemic infection due to B. pseudomallei, which
often causes multiple abscesses. Taiwan was not
considered an endemic area until 2001,7 after
publication of the first two indigenous cases in
1996.6 Liver abscess is not an infrequent manifes-
tation of melioidosis; however, only two cases of
this condition have been previously reported in
Taiwan.10,11 Both K. pneumoniae liver abscess and
melioidosis are associated with diabetes mellitus.
Other reported risk factors of melioidosis are
renal disease, liver cirrhosis, thalassemia, alco-
holism, use of immunosuppressive agents, cystic
fibrosis and kava consumption.12
K. pneumoniae liver abscess has a good progno-
sis when treated with adequate drainage and com-
bination antimicrobial therapy for 2–3 weeks.
Poorer outcome is associated with the occurrence
of metastatic infections, rupture of abscess or 
severe sepsis, with a mortality rate of 18% and
relapse rate of 7%.13 In contrast, melioidosis is
difficult to treat, with a slow clinical response to
high dose parenteral antibiotics. The median time
for resolution of fever was 9 days, and may be
even longer in the presence of a large abscess or
empyema.13 The response is so slow that physi-
cians who have no clinical experience with this
disease often tend to change antibiotic regimens
due to fear of drug resistance and treatment fail-
ure. The mortality rate is about 37% in acute sep-
ticemia, but only 4% in nonsepticemic cases.14
fThe relapse rate is about 10%, and rises to 30% i
maintenance antimicrobial agents are not given
for at least 5 months.15 Both mortality and relapse
rates of melioidosis are higher than K. pneumoniae
liver abscess. Therefore, in cases of liver abscess
not due to K. pneumoniae, it is important to keep
in mind the possibility of melioidosis as a cause
of liver abscess in Taiwan. Concurrent infection
with K. pneumoniae and B. pseudomallei thas no
been reported previously and is of uncertain signi-
ficance. However, diabetes mellitus is a predispos-
ing factor for both pathogens. The clinical course
and outcome of Case 1 in this report are typical.
K. pneumoniae causing liver abscess in Taiwan 
tis usually susceptible to many antibiotics (mos  
β-lactams, sulfamethoxazole-trimethoprim and
aminoglycosides) except ampicillin and ticar-
cillin.14 However, B. pseudomallei yis intrinsicall  
resistant to penicillins other than ureidopenicillins,
first- and second-generation cephalosporins, mac-
rolides, rifampins and aminoglycosides,15 and is
only susceptible to chloramphenicol, tetracyclines,
trimethoprim-sulfamethoxazole, ureidopenicillins,
third-generation cephalosporins, carbapenems and
amoxicillin-clavulanate. This difference in anti-
microbial susceptibility will result in ttreatmen
failure when melioidosis is empirically treated 
as K. pneumoniae or other community-acquired, 
enteric Gram-negative bacteria. Resistance to
aminoglycosides in an oxidase-positive, Gram-
negative rod is a useful clue, since B. pseudomallei
is frequently misidentified as Pseudomonas spp.
other than Pseudomonas aeruginosa.16
Ceftazidime (40 mg/kg every 8 hours) is the
antibiotic of choice for melioidosis17 rand othe
third-generation cephalosporins should not be
used despite evidence of good in vitro susceptibil-
ity due to increased mortality rate.18 Imipenem
(20 mg/kg every 8 hours) or intravenous amoxi-
cillin-clavulanate are also alternative choices.19–21
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Parenteral antibiotics should be continued for 
at least 10–14 days, until clear improvement is
noted and the patient is able to take oral medica-
tions. Oral maintenance therapy with amoxicillin-
clavulanate (amoxicillin 27 mg/kg day divided
into three doses) or trimethoprim-sulfamethoxa-
zole (trimethoprim 8 mg/kg/day and sulfamethox-
azole 40 mg/kg/day) should be given for at least
20 weeks.22
The characteristic features of melioidotic liver
abscess on ultrasound or CT are the presence of
multiple, small cavities, appearing like Swiss
cheese, and the involvement of other visceral or-
gans. The spleen is the most common site.23,24
The gold standard for diagnosis is culture of spu-
tum, blood or aspirated pus, which takes several
days. B. pseudomallei can be cultured aerobically
in most agar media within 24 hours at 37°C.15
Throat swab has 90% sensitivity compared to
sputum, especially in a child or patient whose
sputum is not available. Rapid diagnosis may be
achieved by methods including Gram or Wright
stain of the sputum or pus, which will disclose
Gram-negative rods with bipolar staining, shaped
like safety pins. Direct immunofluorescence micro-
scopy is 98% specific and 70% sensitive com-
pared to culture. Other rapid diagnostic methods
include serology tests, such as indirect hemag-
glutination assay.12
In conclusion, K. pneumoniae is the most com-
mon cause of liver abscess in Taiwan in patients
without biliary tract abnormalities. However, in
cases not due to K. pneumoniae, B. pseudomallei
should be kept in mind as a possible pathogen,
since misdiagnosis results in treatment failure and
a high mortality rate. Distinguishing clinical char-
acteristics include travel history to endemic areas
(in imported cases), bipolar staining on a Wright
stain, slow response to treatment, multiple small
abscesses on imaging, concomitant involvement
of other visceral organs, especially the spleen, un-
usual resistance to aminoglycosides and a higher
mortality and relapse rate. Taiwan is now consid-
ered an endemic area for melioidosis, and physi-
cians should include melioidosis in the differential
diagnosis of pyogenic liver abscess in Taiwan.
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